Akso Health Group (AHG) Income Statement (2016 - 2025)
Annual Income Statement report data from Mar 31, 2016 to Mar 31, 2025 for Akso Health Group (AHG).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||
Total Revenue | 15M (+513.28%) | 2.41M (-81.73%) | 13M (+109.03%) | 6.31M (+260.57%) | 1.75M (-74.67%) | 6.91M (+86.76%) | 3.70M (-96.55%) | 107M (+367.98%) | 23M | - |
Cost Of Revenue | 15M (+557.64%) | 2.29M (-80.77%) | 12M | - | - | - | - | - | - | - |
Costof Goods And Services Sold | 15M (+557.64%) | 2.29M (-80.77%) | 12M | - | - | - | - | - | - | - |
Gross Profit | -280.00K | 120K (-90.55%) | 1.27M (+108.20%) | 610K (-65.14%) | 1.75M (-74.67%) | 6.91M | - | 107M (+367.98%) | 23M (+92.77%) | 12M |
Operating Expenses | ||||||||||
Research And Development | - | - | - | 420K (-4.55%) | 440K (+266.67%) | 120K | - | 2.82M (+79.62%) | 1.57M (+74.44%) | 900K |
Selling General And Administrative | 3.64M (-57.63%) | 8.59M (-44.69%) | 16M (+481.65%) | 2.67M (+31.53%) | 2.03M (-90.09%) | 20M (+554.63%) | 3.13M (-46.22%) | 5.82M (+119.62%) | 2.65M (+70.97%) | 1.55M |
Operating Expenses | 166M (+1795.21%) | 8.76M (-43.63%) | 16M (+301.55%) | 3.87M (-8.73%) | 4.24M (-92.29%) | 55M (+405.70%) | 11M (-65.33%) | 31M (+141.20%) | 13M (+67.87%) | 7.75M |
Depreciation And Amortization | 2.15M | - | - | 20K (0.00%) | 20K (-83.33%) | 120K (+500.00%) | 20K (-88.24%) | 170K (+88.89%) | 90K (+50.00%) | 60K |
Operating Income | ||||||||||
Operating Income | -166.30M (+1824.77%) | -8.64M (-39.45%) | -14.27M (+337.73%) | -3.26M (-23.11%) | -4.24M (-91.19%) | -48.11M (+569.12%) | -7.19M | 76M (+665.69%) | 9.91M (+139.37%) | 4.14M |
Ebit | -166.30M (+1824.77%) | -8.64M (-39.45%) | -14.27M (+337.73%) | -3.26M (-23.11%) | -4.24M (-91.19%) | -48.11M (+569.12%) | -7.19M | 76M (+665.69%) | 9.91M (+139.37%) | 4.14M |
EBITDA | -164.15M (+1640.72%) | -9.43M (+603.73%) | -1.34M (-58.64%) | -3.24M (-23.40%) | -4.23M (-91.19%) | -47.99M (+569.32%) | -7.17M | 76M (+659.74%) | 10M (+138.33%) | 4.20M |
Other Income / Expenses | ||||||||||
Interest Expense | - | - | - | 800K (-62.79%) | 2.15M | - | - | - | - | - |
Net Interest Income | - | - | - | -800.00K (-62.79%) | -2.15M | - | - | - | - | - |
Other Non Operating Income | 30K | -450.00K | 1.20M | -750.00K (+1400.00%) | -50.00K | 1.23M (+223.68%) | 380K (-42.42%) | 660K (+266.67%) | 180K (+500.00%) | 30K |
Net Income | ||||||||||
Income Before Tax | -166.27M (+1729.15%) | -9.09M (-30.45%) | -13.07M (+225.94%) | -4.01M (-6.53%) | -4.29M (-90.85%) | -46.87M (+588.25%) | -6.81M | 77M (+658.57%) | 10M (+141.97%) | 4.17M |
Income Tax Expense | -30.80M | 20K (0.00%) | 20K (-77.78%) | 90K (-81.25%) | 480K (-2.04%) | 490K (-39.51%) | 810K (-92.66%) | 11M (+625.66%) | 1.52M (+141.27%) | 630K |
Net Income From Continuing Operations | -134.98M (+1326.85%) | -9.46M (+595.59%) | -1.36M (-91.93%) | -16.85M (-51.62%) | -34.83M (-51.08%) | -71.20M | 5.53M (-91.55%) | 65M (+664.06%) | 8.57M (+142.09%) | 3.54M |
Net Income | -134.98M (+1326.85%) | -9.46M (+595.59%) | -1.36M (-91.93%) | -16.85M (-51.62%) | -34.83M (-51.08%) | -71.20M | 5.53M (-91.55%) | 65M (+664.06%) | 8.57M (+142.09%) | 3.54M |
Comprehensive Income Net Of Tax | -135.15M (+1284.73%) | -9.76M (+182.90%) | -3.45M (-77.60%) | -15.40M (-50.13%) | -30.88M (-59.63%) | -76.49M (+12648.33%) | -600.00K | 71M (+853.40%) | 7.49M (+144.77%) | 3.06M |